By Dr Abhi Pal

Conference Abstracts

Arulananda S; Pham R; Singh A; Khattak MA; Lin P; Pal A; Nindra U; Chew CG; Singhal N; Ngai S; O'Byrne KJ; Emmett L; Chin VT; Ramdave S; Hicks RJ; Preston JK; Jordaan P; Gericke GH; Cardaci G, 2026, 'LuSato-1: Phase I study of 177Lu-SSO110 with 68Ga-SSO120 companion imaging in patients with extensive stage small cell lung cancer (ES-SCLC) on maintenance treatment with immune checkpoint inhibition (ICI).', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 44, pp. 8011 - 8011, http://dx.doi.org/10.1200/jco.2026.44.16_suppl.8011

Simonelli M; Rojas CI; Dziadziuszko R; Park JO; Xue J; Felip E; Garcia VM; Bar J; Lakhani N; Kwiatkowski M; Ahern ES; Lee J; Joerger M; Stathis A; Pal A; Dizdar O; Jemielita T; Choi SY; Molife RL; Sacher A, 2025, '926MO MK-1084 monotherapy in participants (Pts) with KRAS G12C–mutated advanced solid tumors: Activity and safety in the phase I KANDLELIT-001 study', in Annals of Oncology, Elsevier, Vol. 36, pp. s606 - s607, http://dx.doi.org/10.1016/j.annonc.2025.08.1495

Back to profile page